Oncophage (HSPPC-96): Phase I/II trial update

Antigenics Inc. (AGEN), New York, N.Y. Product: Oncophage ( HSPPC-96) Business: Cancer Therapeutic category: Immune stimulation Target: Immune system Description: Heat shock protein vaccine derived f...